中华医学超声杂志(电子版)
中華醫學超聲雜誌(電子版)
중화의학초성잡지(전자판)
CHINESE JOURNAL OF MEDICAL ULTRASOUND(ELECTRONICAL VISION)
2015年
6期
488-492
,共5页
成雪晴%卢漫%贺凡丁%郭璇妍
成雪晴%盧漫%賀凡丁%郭璇妍
성설청%로만%하범정%곽선연
滑囊炎%超声检查,介入性%玻璃酸钠%复方倍他米松
滑囊炎%超聲檢查,介入性%玻璃痠鈉%複方倍他米鬆
활낭염%초성검사,개입성%파리산납%복방배타미송
Bursitis%Ultrasonography,interventional%Hyaluronate%Betamethasone
目的:评价超声引导下复方倍他米松联合玻璃酸钠注射治疗肩峰下滑囊炎(SAB)的疗效。方法收集2013年1月至2014年9月因肩部疼痛于四川省人民医院附属医院超声科就诊的门诊患者200例,将其中72例诊断为单纯性SAB且欲行超声引导下肩峰下滑囊注射治疗的患者纳入本研究,随机分为2组。试验组给予复方倍他米松联合玻璃酸钠注射,对照组给予复方倍他米松注射,所有患者治疗后第1周和第4周进行电话随访,治疗前、后均进行疼痛评分(视觉模拟评分法, VAS)和肩关节主动外展活动度评分。结果2组患者治疗后1周和4周,VAS评分及肩关节主动外展活动度评分均较治疗前明显改善(P均<0.05)。治疗后1周,试验组与对照组VAS评分及肩关节主动外展活动度评分比较,差异无统计学意义(P均>0.05);治疗后4周,试验组VAS评分明显低于对照组(2.08±1.95vs 3.14±2.0,P<0.05),试验组肩关节主动外展活动度评分明显高于对照组(7.12±2.10vs 6.11±1.93,P<0.05)。结论超声引导下肩峰下滑囊内复方倍他米松联合玻璃酸钠注射可有效治疗SAB,其缓解疼痛及改善肩关节主动外展活动范围的短期疗效优于单一使用复方倍他米松注射治疗。
目的:評價超聲引導下複方倍他米鬆聯閤玻璃痠鈉註射治療肩峰下滑囊炎(SAB)的療效。方法收集2013年1月至2014年9月因肩部疼痛于四川省人民醫院附屬醫院超聲科就診的門診患者200例,將其中72例診斷為單純性SAB且欲行超聲引導下肩峰下滑囊註射治療的患者納入本研究,隨機分為2組。試驗組給予複方倍他米鬆聯閤玻璃痠鈉註射,對照組給予複方倍他米鬆註射,所有患者治療後第1週和第4週進行電話隨訪,治療前、後均進行疼痛評分(視覺模擬評分法, VAS)和肩關節主動外展活動度評分。結果2組患者治療後1週和4週,VAS評分及肩關節主動外展活動度評分均較治療前明顯改善(P均<0.05)。治療後1週,試驗組與對照組VAS評分及肩關節主動外展活動度評分比較,差異無統計學意義(P均>0.05);治療後4週,試驗組VAS評分明顯低于對照組(2.08±1.95vs 3.14±2.0,P<0.05),試驗組肩關節主動外展活動度評分明顯高于對照組(7.12±2.10vs 6.11±1.93,P<0.05)。結論超聲引導下肩峰下滑囊內複方倍他米鬆聯閤玻璃痠鈉註射可有效治療SAB,其緩解疼痛及改善肩關節主動外展活動範圍的短期療效優于單一使用複方倍他米鬆註射治療。
목적:평개초성인도하복방배타미송연합파리산납주사치료견봉하활낭염(SAB)적료효。방법수집2013년1월지2014년9월인견부동통우사천성인민의원부속의원초성과취진적문진환자200례,장기중72례진단위단순성SAB차욕행초성인도하견봉하활낭주사치료적환자납입본연구,수궤분위2조。시험조급여복방배타미송연합파리산납주사,대조조급여복방배타미송주사,소유환자치료후제1주화제4주진행전화수방,치료전、후균진행동통평분(시각모의평분법, VAS)화견관절주동외전활동도평분。결과2조환자치료후1주화4주,VAS평분급견관절주동외전활동도평분균교치료전명현개선(P균<0.05)。치료후1주,시험조여대조조VAS평분급견관절주동외전활동도평분비교,차이무통계학의의(P균>0.05);치료후4주,시험조VAS평분명현저우대조조(2.08±1.95vs 3.14±2.0,P<0.05),시험조견관절주동외전활동도평분명현고우대조조(7.12±2.10vs 6.11±1.93,P<0.05)。결론초성인도하견봉하활낭내복방배타미송연합파리산납주사가유효치료SAB,기완해동통급개선견관절주동외전활동범위적단기료효우우단일사용복방배타미송주사치료。
ObjectiveTo evaluate the effectiveness of ultrasound-guided (US-guided) subacromial bursa injection of betamethasone combined with hyaluronate for treatment of subacromial bursitis.MethodsA total of 72 patients who were diagnosed as subacromial bursitis by ultrasound and then decided to performed US-guided subacromial bursa injection were randomly divided into two groups. The study group was treated with compound betamethasone suspension followed by sodium hyaluronate, and the control group was treated only with compound betamethasone suspension. Visual analogue score (VAS) and the shoulder active abduction range of motion (AAROM) score were observed before treatment, 1 week and 4 weeks post-treatment during 1 month's followed-up.ResultsThere were signifi cantly decreased in VAS score and increased in AAROM score at 1 week and 4 weeks post treatment for both groups (bothP<0.05). There was no difference of both VAS score and AAROM score between the two groups at 1 week post treatment (bothP>0.05). But at 4 weeks post treatment, the VAS score of the study group was signifi cantly lower than that of the control group (2.08±1.95vs 3.14±2.0,P<0.05), while the AAROM score of the study group was signifi cantly higher than that of the control group (7.12±2.10vs 6.11±1.93,P<0.05). ConclusionsUltrasound-guided subacromial bursa injection of betamethasone combined with hyaluronate is effective in treating subacromial bursitis. It produces better pain and active abduction functional improvement than betamethasone at a short-term follow-up.